A

Ascentage Pharma Group International
6855

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
HK$17.64B
EV
HK$18.08B
Shares Outstanding
350.83M
Beta
1.00

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$51.91
P/E 2025E
-
P/Revenue 2025E
27.92x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Ascentage Pharma Group International

gainify

A

Ascentage Pharma Group International

6855

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company’s primary product candidate is HQP1351, a BCR-ABL inhibitor targeting...

Sector

Healthcare

Industry

Biotechnology

CEO

Yang, Dajun

Employees

567

IPO Date

2019-10-28

Headquarters

Suzhou Industrial Park, 68 Xinqing Road, Suzhou, Jiangsu Province, 215000, China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved